secwatch.observer — SEC 8-K summary
======================================

Issuer:     Annovis Bio, Inc. (ANVS)
CIK:        0001477845
Form:       8-K
Filed at:   2024-03-20T23:59:59+00:00
Accession:  0001104659-24-036331
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Annovis Bio closes $1.025M offering, issues 114,911 shares at $8.92
-------------------------------------------------------------------

- Raised $1,025,000 gross proceeds from a registered direct offering with an institutional investor.
- Issued 114,911 shares of common stock at $8.92 per share.
- Offering closed on March 19, 2024; shares issued under effective Form S-3 shelf registration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477845/000110465924036331/0001104659-24-036331-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477845/000110465924036331/tm248202d3_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-036331

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer